This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Targeting Micrometastases: The Effect of Heterogeneous Radionuclide Distribution on Tumor Control Probability
- Molecular Radiotherapy Using Cleavable Radioimmunoconjugates That Target EGFR and {gamma}H2AX
- ErbB-2 Blockade and Prenyltransferase Inhibition Alter Epidermal Growth Factor and Epidermal Growth Factor Receptor Trafficking and Enhance 111In-DTPA-hEGF Auger Electron Radiation Therapy
- Cellular Dosimetry of 111In Using Monte Carlo N-Particle Computer Code: Comparison with Analytic Methods and Correlation with In Vitro Cytotoxicity
- Cancer Nanotargeted Radiopharmaceuticals for Tumor Imaging and Therapy
- Targeted In vivo Imaging of Integrin {alpha}v{beta}6 with an Improved Radiotracer and Its Relevance in a Pancreatic Tumor Model
- In Vivo SPECT Quantification of Transplanted Cell Survival After Engraftment Using 111In-Tropolone in Infarcted Canine Myocardium
- Relationship Between Induction of Phosphorylated H2AX and Survival in Breast Cancer Cells Exposed to 111In-DTPA-hEGF
- Imaging Epidermal Growth Factor Receptor Expression In vivo: Pharmacokinetic and Biodistribution Characterization of a Bioconjugated Quantum Dot Nanoprobe
- Epidermal Growth Factor Receptor Inhibition Modulates the Nuclear Localization and Cytotoxicity of the Auger Electron Emitting Radiopharmaceutical 111In-DTPA Human Epidermal Growth Factor
- 111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer
- Carbon Nanotubes: Potential Benefits and Risks of Nanotechnology in Nuclear Medicine
- [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor-Targeted Therapy for Insulinoma
- Preclinical Pharmacokinetic, Biodistribution, Toxicology, and Dosimetry Studies of 111In-DTPA-Human Epidermal Growth Factor: An Auger Electron-Emitting Radiotherapeutic Agent for Epidermal Growth Factor Receptor-Positive Breast Cancer
- Auger Electrons: Lethal, Low Energy, and Coming Soon to a Tumor Cell Nucleus Near You
- A Kit Formulated Under Good Manufacturing Practices for Labeling Human Epidermal Growth Factor with 111In for Radiotherapeutic Applications
- Cancer Therapy with Auger Electrons: Are We Almost There?
- Antitumor Effects and Normal Tissue Toxicity of 111In-Labeled Epidermal Growth Factor Administered to Athymic Mice Bearing Epidermal Growth Factor Receptor-Positive Human Breast Cancer Xenografts